Ion Beam Applications SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
IBA (Ion Beam Applications) Announces FY 2013 Revenue Guidance Below Analysts' Estimates and FY 2013 Net Profit Outlook
IBA (Ion Beam Applications) announced that the Company anticipates low single-digit growth in Group revenues in 2013, based on a Proton Therapy order intake of eight to 12 rooms and service revenue growing from EUR 17 million to approximately EUR 24 million. According to I/B/E/S estimates analysts on average are expecting the Company to report FY 2013 revenue of EUR 341.06 million. The Company reported FY 2012 revenue of EUR 221.11 million. The Company also expects to report positive net profits during 2013.
Latest Key Developments in Advanced
- Cerner Corp gives Q4 2014 guidance in line with analysts' estimates
- Edwards Lifesciences Corp sees FY 2014 revenue guidance to exceed high end of prior range; raises FY 2014 EPS guidance; gives Q4 2014 guidance in line with analysts' estimates
- Spectranetics Corp raises FY 2014 guidance
- Hamilton Thorne announces private placement unit offering of up to C$750,000
- Share this
- Digg this